| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-07 |
| mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |
| mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
2e-06 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
1e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |